MEPHA regresa a casa.../ Switzerland's Acino grabs more Mepha business from Teva

Teva Pharmaceutical Industries is selling the Latin American and Asian businesses of its Mepha generics unit to Swiss drugmaker Acino.

The deal comes a couple of months after it was announced that Acino was going to buy the Middle East and African business of Cephalon, which had itself just been acquired by Teva. For that deal, Acino was going to pay 60 million euros in cash and 20 million euros in new shares but the total purchase price for the four business operations, plus the Mepha site in Aesch, Switzerland and certain other considerations now amounts to 94 million euros. (Más)

Ver

Article Switzerland's Acino grabs more Mepha business from Teva

MEPHA ya tiene dueño...CEPHALON.

Merckle y Ratiopharm tambien son MEPHA...